Neil R Johnston
Overview
Explore the profile of Neil R Johnston including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
528
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sandilands E, Rees J, Raja K, Dhaun N, Morrison E, Hickson K, et al.
Clin Pharmacol Ther
. 2022 Jan;
111(6):1222-1238.
PMID: 35098531
Contrast-induced nephropathy (CIN) is a major complication of imaging in patients with chronic kidney disease (CKD). The publication of an academic randomized controlled trial (RCT; n = 83) reporting oral...
2.
Anand A, Farrah T, Miller-Hodges E, Shah A, Strachan F, Carter E, et al.
Nephrol Dial Transplant
. 2020 Sep;
36(2):375-377.
PMID: 32984897
No abstract available.
3.
Ras R, Zock P, Zebregs Y, Johnston N, Webb D, Draijer R
Br J Nutr
. 2013 May;
110(12):2234-41.
PMID: 23702253
Dietary polyphenols, such as those from grape products, may exert beneficial effects on cardiovascular health, including anti-hypertensive effects. We investigated the effect of a specific grape seed extract (GSE) rich...
4.
Sandilands E, Crowe J, Cuthbert H, Jenkins P, Johnston N, Eddleston M, et al.
Br J Clin Pharmacol
. 2013 Mar;
76(5):699-707.
PMID: 23488545
Aim: To investigate the mechanism of action of intra-arterial histamine in the human forearm vasculature. Methods: Three studies were conducted to assess changes in forearm blood flow (FBF) using venous...
5.
Dhaun N, Melville V, Blackwell S, Talwar D, Johnston N, Goddard J, et al.
J Am Soc Nephrol
. 2012 Dec;
24(1):31-6.
PMID: 23243212
Arterial stiffness and impaired nitric oxide (NO) bioavailability contribute to the high risk for cardiovascular disease in CKD. Both asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO production, and endothelin-1...
6.
Sandilands E, Cameron S, Paterson F, Donaldson S, Briody L, Crowe J, et al.
BMC Clin Pharmacol
. 2012 Feb;
12:3.
PMID: 22305183
Background: Contrast-induced nephropathy is a common complication of contrast administration in patients with chronic kidney disease and diabetes. Its pathophysiology is not well understood; similarly the role of intravenous or...
7.
Dhaun N, Johnston N, Goddard J, Webb D
Hypertension
. 2011 Jun;
58(2):e11-2.
PMID: 21709210
No abstract available.
8.
Dhaun N, MacIntyre I, Kerr D, Melville V, Johnston N, Haughie S, et al.
Hypertension
. 2011 Mar;
57(4):772-9.
PMID: 21357275
Proteinuria is associated with adverse cardiovascular and renal outcomes that are not prevented by current treatments. Endothelin 1 promotes the development and progression of chronic kidney disease and associated cardiovascular...
9.
Langrish J, Lundback M, Mills N, Johnston N, Webb D, Sandstrom T, et al.
Hypertension
. 2009 Aug;
54(4):910-5.
PMID: 19687345
Diesel exhaust inhalation impairs vascular function, and, although the underlying mechanism remains unclear, endothelin (ET) 1 and NO are potential mediators. The aim of this study was to identify whether...
10.
Dhaun N, MacIntyre I, Melville V, Lilitkarntakul P, Johnston N, Goddard J, et al.
Hypertension
. 2009 Aug;
54(3):e19-20.
PMID: 19652085
No abstract available.